More from oncology cro
More in Politics
Related Blogs
Archives
Social Share
Cost-Effectiveness For Contract Research Organization
Posted By oncology cro
Body
Contract Research Organization have the expertise and resources to conduct trials, they can often save a sponsor critical time during the trial phase. Additionally, they can reduce the cost of conducting a trial and can even reduce the time it takes to complete the trial.
Cost-effectiveness analyses can be controversial and difficult to compare. In practice, the process is often opaque, based on a narrow definition of costs. For example, a researcher may choose to focus on only the Contract Research Organization variable costs associated with providing a service. However, this definition does not account for fixed costs such as infrastructure and installed capacity.
Cost-effectiveness analysis helps inform public policy. By comparing the health benefits and economic costs of various medical treatments, cost-effectiveness analysis can help ensure that society does not overpay for care that is not necessary. This approach is becoming more common in the health care industry, where drug companies are increasingly outsourcing their medical testing responsibilities.
This way, they can reduce their research costs and relieve themselves of the ongoing costs associated with full-time staff, medical facilities, and the ongoing management of trials. When determining the cost-effectiveness of health interventions, the burden of disease must be considered.
Some interventions may be relatively effective but only benefit a small number of people. For instance, leishmaniasis treatment is cost-effective but only affects a small percentage of the population. Similarly, insecticide-treated bednets are cost-effective, even when only a small number of people use them.
This way, they can reduce their research costs and relieve themselves of the ongoing costs associated with full-time staff, medical facilities, and the ongoing management of trials. When determining the cost-effectiveness of health interventions, the burden of disease must be considered.
Some interventions may be relatively effective but only benefit a small number of people. For instance, leishmaniasis treatment is cost-effective but only affects a small percentage of the population. Similarly, insecticide-treated bednets are cost-effective, even when only a small number of people use them.
Comments